Key facts
- Zageno’s last known valuation is $300.0M (Nov 2021).
- It has raised $128.9M across 2 recorded rounds; the latest was Early Stage VC ($8.0M) in Aug 2025.
- Notable investors include FJ Labs, General Catalyst, Capnamic Ventures, Zachary Weinberg, Kaiser Permanente — 12 tracked in total.
- Zageno has filed 2 Form Ds with the SEC since 2017, most recently Aug 2025 ($8.0M sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Zageno
Funding rounds
2 roundsAbout Zageno
Operator of a life science marketplace intended to simplify the process of providing research scientists with what they need. The company's marketplace makes online shopping for any research material convenient, and reliable with a product rating system that offers impartial and peer-reviewed ratings, enabling life science researchers to save time and money while making more informed purchasing decisions.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2015
- Employees
- 155
- Website
- zageno.com/
- Ownership
- Privately Held (backing)
Zageno doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zageno shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zageno in its N-PORT filings yet. We sweep new filings monthly.